BEIJING - CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND ...
BEIJING - CASI Pharmaceuticals, Inc. (NASDAQ: CASI ), a biopharmaceutical company, has announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) ...